Profile data is unavailable for this security.
About the company
Merit Medical Systems, Inc. designs, develops, manufactures, markets and sells medical products for interventional and diagnostic procedures. The Company is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions and original equipment manufacturer. Within these product categories, it sells a variety of products, including cardiology and radiology devices, as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care and others. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.
- Revenue in USD (TTM)1.26bn
- Net income in USD94.41m
- Incorporated1987
- Employees6.95k
- LocationMerit Medical Systems Inc1600 West Merit Park WaySOUTH JORDAN 84095United StatesUSA
- Phone+1 (801) 253-1600
- Fax+1 (801) 253-1652
- Websitehttps://www.merit.com/
Mergers & acquisitions
Acquired company | MMSI:NSQ since announced | Transaction value |
---|---|---|
AngioDynamics Inc-Dialysis Catherer Portfolio & BioSentry Product | -13.44% | 100.00m |
Bluegrass Vascular Technologies Inc-Surfacer Inside-Out Access Catheter System | -13.44% | 32.50m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patterson Companies, Inc. | 6.57bn | 193.86m | 2.31bn | 7.60k | 12.72 | 2.39 | 8.25 | 0.352 | 2.03 | 2.03 | 68.86 | 10.78 | 2.23 | 5.61 | 14.48 | 864,047.90 | 6.58 | 0.3702 | 11.30 | 0.5655 | 21.30 | 21.05 | 2.95 | 0.1811 | 0.7243 | 12.08 | 0.4462 | 846.10 | -0.4298 | 3.44 | 2.14 | 10.79 | 8.22 | 0.00 |
Tandem Diabetes Care Inc | 747.72m | -222.61m | 2.33bn | 2.40k | -- | 7.43 | -- | 3.12 | -3.44 | -3.44 | 11.51 | 4.78 | 0.7457 | 2.82 | 6.79 | 311,549.20 | -22.20 | -10.08 | -27.07 | -12.23 | 49.17 | 51.77 | -29.77 | -11.59 | 3.02 | -- | 0.4761 | -- | -6.68 | 32.39 | -135.33 | -- | 76.81 | -- |
Premier Inc | 1.32bn | 167.33m | 2.49bn | 2.80k | 14.93 | 1.04 | 8.48 | 1.89 | 1.39 | 1.39 | 10.97 | 19.95 | 0.3571 | 4.57 | 3.06 | 470,033.20 | 4.42 | 10.39 | 5.67 | 13.00 | 67.13 | 62.04 | 12.37 | 22.60 | 1.32 | 516.34 | 0.2431 | 19.11 | -6.76 | 2.44 | -34.17 | -15.30 | -2.29 | -- |
Procept Biorobotics Corp | 136.19m | -105.90m | 2.66bn | 626.00 | -- | 9.45 | -- | 19.56 | -2.24 | -2.24 | 2.88 | 5.53 | 0.3815 | 1.91 | 4.28 | 217,557.50 | -29.66 | -- | -33.47 | -- | 52.17 | -- | -77.75 | -- | 6.77 | -- | 0.1546 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
TransMedics Group Inc | 241.62m | -25.03m | 2.93bn | 584.00 | -- | 21.25 | -- | 12.13 | -0.7685 | -0.7685 | 7.43 | 4.20 | 0.4915 | 2.70 | 5.30 | 413,738.00 | -5.09 | -16.08 | -5.53 | -17.95 | 63.77 | 65.37 | -10.36 | -40.47 | 8.49 | -- | 0.7868 | -- | 158.53 | 79.36 | 30.92 | -- | 225.12 | -- |
LivaNova PLC | 1.15bn | 17.55m | 2.97bn | 2.90k | 171.00 | 2.33 | 43.81 | 2.58 | 0.3222 | 0.3222 | 21.32 | 23.70 | 0.4883 | 2.76 | 5.79 | 397,774.10 | 0.7472 | -6.01 | 0.8627 | -7.42 | 66.86 | 66.99 | 1.53 | -13.56 | 2.51 | 1.10 | 0.3147 | -- | 12.89 | 0.8278 | 120.34 | -- | -1.64 | -- |
Enovis Corp | 1.71bn | -54.37m | 3.02bn | 6.55k | -- | 0.88 | 18.51 | 1.77 | -0.9987 | -0.6117 | 31.33 | 62.61 | 0.3888 | 1.59 | 6.11 | 260,640.80 | -1.23 | -0.3569 | -1.37 | -0.41 | 58.21 | 48.19 | -3.15 | -1.06 | 1.16 | 1.02 | 0.1199 | -- | 9.22 | -4.89 | -40.29 | -- | 11.91 | -- |
Axonics Inc | 366.38m | -6.09m | 3.39bn | 797.00 | -- | 5.30 | 532.27 | 9.26 | -0.1285 | -0.1285 | 7.43 | 12.56 | 0.5313 | 1.35 | 7.18 | 459,697.60 | -0.8828 | -12.67 | -0.9601 | -13.76 | 74.94 | 70.04 | -1.66 | -29.68 | 8.98 | -- | 0.00 | -- | 33.86 | 249.06 | 89.80 | -- | 23.65 | -- |
Envista Holdings Corp | 2.57bn | -100.20m | 3.44bn | 12.80k | -- | 0.8226 | 97.19 | 1.34 | -0.6022 | -0.6022 | 14.65 | 24.34 | 0.3891 | 3.99 | 6.41 | 200,507.80 | -1.52 | 1.94 | -1.79 | 2.34 | 56.52 | 57.65 | -3.90 | 5.29 | 1.90 | 5.12 | 0.2661 | 0.00 | -0.1012 | -2.04 | -142.10 | -- | -4.22 | -- |
Integer Holdings Corp | 1.63bn | 98.09m | 3.72bn | 10.50k | 38.54 | 2.44 | 18.71 | 2.28 | 2.88 | 2.88 | 47.86 | 45.52 | 0.5452 | 4.92 | 4.95 | 155,494.60 | 3.28 | 3.28 | 3.53 | 3.53 | 26.52 | 26.94 | 6.01 | 6.40 | 2.01 | 3.66 | 0.4303 | 0.00 | 16.03 | 5.62 | 38.71 | 9.33 | 21.71 | -- |
Merit Medical Systems Inc | 1.26bn | 94.41m | 4.26bn | 6.95k | 45.36 | 3.53 | 23.11 | 3.39 | 1.62 | 1.62 | 21.55 | 20.78 | 0.6304 | 2.36 | 7.34 | 180,916.00 | 4.73 | 2.45 | 5.30 | 2.77 | 46.44 | 44.50 | 7.51 | 3.91 | 3.95 | 9.89 | 0.4064 | 0.00 | 9.24 | 7.33 | 26.70 | 15.86 | -11.16 | -- |
Haemonetics Corporation | 1.27bn | 126.57m | 4.45bn | 3.03k | 35.47 | 4.72 | 20.24 | 3.50 | 2.47 | 2.47 | 24.80 | 18.57 | 0.6229 | 2.11 | 6.47 | 418,649.00 | 6.21 | 4.74 | 7.05 | 5.89 | 53.48 | 49.87 | 9.97 | 7.41 | 1.76 | 26.49 | 0.48 | 0.00 | 17.67 | 5.27 | 166.05 | 9.48 | 8.06 | -- |
Lantheus Holdings Inc | 1.30bn | 326.66m | 4.47bn | 834.00 | 14.05 | 5.48 | 11.56 | 3.45 | 4.64 | 4.64 | 18.59 | 11.91 | 0.8723 | 9.46 | 5.21 | 1,554,471.00 | 21.98 | 6.69 | 25.75 | 7.73 | 63.71 | 53.90 | 25.20 | 9.02 | 5.45 | 1,235.43 | 0.4081 | 0.00 | 38.65 | 30.44 | 1,063.86 | 51.81 | 35.48 | -- |
Glaukos Corp | 314.71m | -134.66m | 5.00bn | 907.00 | -- | 10.65 | -- | 15.90 | -2.78 | -2.78 | 6.50 | 9.40 | 0.324 | 1.89 | 8.29 | 346,980.20 | -13.86 | -8.73 | -14.99 | -9.35 | 75.99 | 74.77 | -42.79 | -28.69 | 4.78 | -27.68 | 0.4335 | -- | 11.26 | 11.66 | -35.75 | -- | 14.44 | -- |
Novanta Inc | 881.66m | 72.88m | 5.61bn | 2.90k | 77.25 | 8.31 | 46.93 | 6.36 | 2.02 | 2.02 | 24.47 | 18.80 | 0.7147 | 3.04 | 6.36 | 304,021.40 | 5.91 | 5.46 | 6.74 | 6.34 | 45.36 | 43.24 | 8.27 | 7.71 | 1.91 | 4.83 | 0.3477 | 0.00 | 2.41 | 7.49 | -1.58 | 8.21 | 4.19 | -- |
Holder | Shares | % Held |
---|---|---|
BlackRock Fund Advisorsas of 31 Dec 2023 | 8.70m | 15.03% |
The Vanguard Group, Inc.as of 31 Dec 2023 | 6.72m | 11.60% |
William Blair Investment Management LLCas of 31 Dec 2023 | 3.82m | 6.59% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 2.22m | 3.84% |
ArrowMark Colorado Holdings LLCas of 31 Dec 2023 | 2.19m | 3.78% |
Conestoga Capital Advisors LLCas of 31 Dec 2023 | 2.15m | 3.72% |
Fuller & Thaler Asset Management, Inc.as of 31 Dec 2023 | 1.42m | 2.45% |
Dimensional Fund Advisors LPas of 31 Dec 2023 | 1.31m | 2.26% |
Macquarie Investment Management Business Trustas of 31 Dec 2023 | 1.28m | 2.21% |
Geode Capital Management LLCas of 31 Dec 2023 | 1.25m | 2.16% |